跳至主要内容
临床试验/IRCT2015110224825N1
IRCT2015110224825N1已完成未知

Comparing clarithromycin-based triple therapy Helicobacter pylori eradication with triple therapy containing levofloxacin

Mazandaran University of medical sciences,Deputy of Research and Technology0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
76 years 至 no limit(—)
性别
All

入选标准

  • inclusion criteria: All patients underwent endoscopy with duodenal ulcer or gastric or duodenal or stomach inflammation and Erosion referred to the clinic / office professor interviewed Sari hospital reported that Helicobacter pylori positive and study are older than 18 years
  • Exclusion criteria: Pregnancy and breastfeeding; H. pylori eradication has already been received; During the last two weeks patients with PPI or H2 RA (histamine 2 receptor antagonist), or within the last 4 weeks have received antibiotics or bismuth; Concomitant use of anticoagulants; corticosteroids or ketoconazole; Patients with a history of stomach surgery; Patients with advanced disease confirmed and severe cardiac; pulmonary;Endocrine; chronic renal failure; chronic liver disease and cancer; alcohol consumption; With a history of peptic ulcer bleeding ulcer complications

排除标准

  • 未提供

研究者

发起方
Mazandaran University of medical sciences,Deputy of Research and Technology

相似试验